Clinical trial
Efficacy, Tolerability and Acceptability of the Single Table Regimen (STR) Biktarvy® by Trans People Living With HIV (TPLWH)
NCT04944654 is registered in ClinicalTrials.gov with Chelsea and Westminster NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy, Tolerability and Acceptability of the Single Table Regimen (STR) Biktarvy® by Trans People Living With HIV (TPLWH)
- Lead sponsor
- Chelsea and Westminster NHS Foundation Trust
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- January 7, 2023
- Completion date
- May 11, 2023
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
human immunodeficiency virus